Newsroom

Chronic diseases kill 38 million people per year worldwide; almost three-quarters of those deaths occur in low- and middle-income countries. It’s time to act.

Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.

Novartis collaborates with the Banner Alzheimer’s Institute to test treatments for preventing Alzheimer’s disease.

We surveyed 7,000 people in seven countries to find out what they know about multiple sclerosis (MS). Our survey identified several surprising misconceptions.

Learn how NIBR uses next generation sequencing to transform clinical trials and diagnostics in oncology.

Patients are learning to live with a chronic disease that will affect one in 5 people over age 40.

Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.

Chronic diseases like cancer and diabetes were once the preserve of wealthy countries but are now increasingly common in lower-income countries too as populations age and lifestyles change.

Healthcare worker Dismus Mwalukwanda is on the front line of the battle against malaria. Saving lives is his priority.

Chinweike Ukomadu thinks that notions about clinicians turning their backs on patients when transitioning to industry are outdated.

A strong background in biological research prepared Daniel Rooks for his role in shaping the early clinical development of new medicines